Huaxian Pharmaceutical is a research and development company of pharmaceutical specialty raw materials and intermediates. It develops high-difficulty specialty raw materials and intermediates in the fields of anti-tumor, anti-virus, and anti-respiratory diseases, and provides high value-added and cost-effective solutions for domestic and foreign pharmaceutical companies. product. Recently completed the B+ round of financing exceeding 100 million yuan. This round of financing was jointly led by Yueke Zhuxi (Yueke Group) and Tuowei Zhonghui, jointly invested by Jiande High-speed Railway New Area Investment and Yueke Huaxian (Yueke Group) Following the investment, Xingyuan Zhitong acted as the exclusive financial advisor for this transaction. This round of financing will be mainly used for the construction of the East China R&D center and the expansion of new production capacity, so as to accelerate the deployment of the business layout in the Yangtze River Delta region.
This article is transferred from: https://www.itjuzi.com/investevent/13723944
This site is only for collection, and the copyright belongs to the original author.